Medical Cannabis and Alcohol Use Disorder (AUD)
CBD has been reported to aid the treatment of alcohol use disorder, more commonly known as alcoholism. In addition to decreasing alcohol cravings, the substance is also an anti-inflammatory, which might lend a hand to the treatment of alcohol-induced brain swelling. Researchers have found that CBD can also help prevent alcohol-induced cell damage, which is a result of alcohol consumption.
Alcoholism: What is it?
A person with alcoholism is someone who is physically and psychologically dependent on alcohol. The Center for Disease Control (CDC) reports that excessive alcohol consumption is a growing problem in the United States, with 6 people dying from alcohol poisoning every day. Additionally, it is worth noting that according to the National Institute on Alcohol Abuse and Alcoholism, in 2018, 14,4 million people aged 18 or older have an addiction illness, while 401,000 young people have AUD.
AUD is characterized by a variety of symptoms. There are several negative side effects of drinking too much alcohol, including nausea, vomiting, drowsiness, and blackouts. The fact that an individual drinks more than intended despite the negative effects of drinking is an indication that he or she has an alcohol addiction. Among the effects of alcohol are the depressant effect it has on the brain, in addition to affecting other organs such as the liver, the pancreas, the heart, and the immune system. The physical symptoms of AUD include sweating, vomiting, weight loss and weight gain, unexplained bruises, and rapid weight loss.
Medical cannabis for treating alcoholism
According to a new study published in Frontiers in Pharmacology published in 2019, CBD may be able to prevent or reduce alcohol-related brain damage and liver disease. It has been suggested that CBD might have a positive impact on both hepatic and neurocognitive outcomes in people with AUD, regardless of their drinking trajectory by reducing alcohol-related steatosis processes in the liver and by reversing alcohol-induced brain damage.
As a novel candidate for AUD pharmacotherapy, the article “Cannabidiol as a Novel Candidate in 2019: A Case Study” concludes that CBD has therapeutic potential. CBD has the potential to treat alcohol-related challenges and addiction phenotypes and offers hope for future study and research on AUD pharmacotherapy. A 2018 study report in the journal Neuropsychopharmacology concluded that rats that self-administered alcohol or cocaine may receive transdermal CBD at intervals of
Study authors suggest that CBD may have protective effects that may help prevent relapse in alcohol addiction in at least two ways: CBD has robust results with short-term treatment and resilient outcomes with long-term therapy. Based on the conclusions of this study, it will be necessary to further characterize CBD’s “therapeutic” profile in the future “in order to further prove its putative large-spectrum therapeutic potential.”
In the meantime, the efficacy of CBD therapy for alcoholism has prompted researchers to investigate the use of CBD therapy in order to assist with alcohol addiction. Heavy drinkers are also using CBD-infused beverages to help them quit drinking alcohol and switch over to water in order to quit drinking alcohol.
Despite the fact that more research is needed, the current results are promising. The effects of CBD on AUD and other addictive behaviors may be enhanced by combining a number of various treatment methods. It was found that alcoholics who have utilized CBD as well as medical cannabis for reducing alcohol consumption had better outcomes than those who did not make use of either substance.